Literature DB >> 12390514

Structural role of zinc ions bound to postsynaptic densities.

Huei-Hsuan Jan1, I-Tong Chen, Yu-Yi Tsai, Yen-Chung Chang.   

Abstract

Postsynaptic densities (PSDs) isolated from porcine cerebral cortices are large aggregates consisting of more than 30 different proteins. Inductively coupled plasma-mass spectrometric analyses revealed that isolated PSDs contained zinc at a concentration of 4.1 nmol per mg protein. Treatment with 8 m urea lead to dissociation of the PSDs into small components and, concomitantly, depletion of most of their bound zinc. After removal of the urea by dialysis, urea-dissociated PSD proteins did not reassemble into aggregates by themselves. Adding ZnCl2 to urea-treated PSD samples resulted in the assembly of urea-dissociated proteins into large aggregates with morphology and protein composition closely resembling those of the original PSDs. Mg2+, Ca2+, Co2+, Cd2+, Cu2+, Mn2+, Fe3+, K+ and Na+ ions at higher concentrations also induced the aggregation of urea-dissociated PSD protein. The structures of the K+-, Na+-, Mg2+- and Ca2+-induced aggregates were distinct from that of the original PSDs. Our results indicate that the structure of the PSD could be disassembled and reassembled under in vitro conditions. They further suggest that Zn2+ ions, by binding to certain zinc-binding proteins, play an important role in the formation and maintenance of the structure of the PSD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390514     DOI: 10.1046/j.1471-4159.2002.01093.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review.

Authors:  Andreas M Grabrucker; Magali Rowan; Craig C Garner
Journal:  Drug Deliv Lett       Date:  2011-09

2.  Expression Analysis of Zinc Transporters in Nervous Tissue Cells Reveals Neuronal and Synaptic Localization of ZIP4.

Authors:  Chiara A De Benedictis; Claudia Haffke; Simone Hagmeyer; Ann Katrin Sauer; Andreas M Grabrucker
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

3.  Environmental factors in autism.

Authors:  Andreas M Grabrucker
Journal:  Front Psychiatry       Date:  2013-01-18       Impact factor: 4.157

4.  Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation.

Authors:  Andreas M Grabrucker; Mary J Knight; Christian Proepper; Juergen Bockmann; Marisa Joubert; Magali Rowan; G Uirich Nienhaus; Craig C Garner; Jim U Bowie; Michael R Kreutz; Eckart D Gundelfinger; Tobias M Boeckers
Journal:  EMBO J       Date:  2011-01-07       Impact factor: 11.598

5.  Modulation of neuronal signal transduction and memory formation by synaptic zinc.

Authors:  Carlos Sindreu; Daniel R Storm
Journal:  Front Behav Neurosci       Date:  2011-11-09       Impact factor: 3.558

6.  Zinc transporter-1 concentrates at the postsynaptic density of hippocampal synapses.

Authors:  Carlos Sindreu; Álex Bayés; Xavier Altafaj; Jeús Pérez-Clausell
Journal:  Mol Brain       Date:  2014-03-07       Impact factor: 4.041

Review 7.  A role for synaptic zinc in ProSAP/Shank PSD scaffold malformation in autism spectrum disorders.

Authors:  Andreas M Grabrucker
Journal:  Dev Neurobiol       Date:  2013-09-11       Impact factor: 3.964

Review 8.  Behavioral impairments in animal models for zinc deficiency.

Authors:  Simone Hagmeyer; Jasmin Carmen Haderspeck; Andreas Martin Grabrucker
Journal:  Front Behav Neurosci       Date:  2015-01-06       Impact factor: 3.558

9.  Effects of trace metal profiles characteristic for autism on synapses in cultured neurons.

Authors:  Simone Hagmeyer; Katharina Mangus; Tobias M Boeckers; Andreas M Grabrucker
Journal:  Neural Plast       Date:  2015-02-23       Impact factor: 3.599

10.  Zinc involvement in opioid addiction and analgesia--should zinc supplementation be recommended for opioid-treated persons?

Authors:  Diana Ciubotariu; Cristina Mihaela Ghiciuc; Cătălina Elena Lupușoru
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.